Jane Street’s Aura Biosciences AURA Stock Holding History

Jane Street’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.62M	Buy	+241,800	New	+$1.39M	﹤0.01%	5486

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jane Street's AURA Position: Q1 2026 in Review

Jane Street sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 47,431 shares — an estimated $272K sold.

Jane Street first reported a position in AURA in Q4 2023 and held it in 6 quarters. The position peaked at $488K in Q2 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

Jane Street reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
Jane Street sold 47,431 Aura Biosciences shares in Q1 2026, an estimated $272K.
Jane Street first reported a position in Aura Biosciences in Q4 2023 and held it in 6 quarters.
Jane Street's Aura Biosciences position peaked at $488K in Q2 2024.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.